logo

Novo Nordisk Extends Programme for Children With Diabetes in Developing Countries

Novo Nordisk 2015年04月14日 16時10分
From 共同通信PRワイヤー

Novo Nordisk Extends Programme for Children With Diabetes in Developing Countries

PR60147

BAGSVAERD, Denmark, Apr. 14, 2015 /PRN=KYODO JBN/ --

Today, Novo Nordisk announced a three-year extension of its Changing
Diabetes(R) in Children programme. Since 2009, free insulin and access to
diabetes care have been provided to more than 13,000 children in nine countries
in Africa and South-East Asia. During the five years, 108 diabetes clinics have
been established and 5,479 healthcare professionals have received diabetes care
training.

To view the Multimedia News Release, please click:

リンク


A child in sub-Saharan Africa diagnosed with type 1 diabetes often has a life
expectancy of less than a year[1]. As a response to this situation and as a
call to action by the International Diabetes Federation, Novo Nordisk
established the Changing Diabetes(R) in Children programme.

The idea originated from a visit to a district hospital in Kenya by Lars Rebien
Sorensen, CEO of Novo Nordisk. At the hospital, he met a Masai boy diagnosed
with type 1 diabetes who had been deserted by his parents at a highway and
taken to the hospital by some passers-by. "It became clear to me that this boy
had dire perspectives for staying alive," says Lars Rebien Sorensen. "This is
obviously hugely disturbing to anyone that has any way of influencing the
situation."

In Guinea, almost 400 children have been enrolled in the programme: "Before we
had the programme for children with diabetes in Guinea, the situation was very
difficult. Many children diagnosed with diabetes had no access to treatment or
stopped it because their parents could not afford to buy insulin," explains
Professor Naby Balde, project partner at Donka University Hospital in Conakry,
Guinea. "It's great progress for the children and their families; they will no
longer have to choose between providing food for the family or treatment of one
child."

The Changing Diabetes(R) in Children programme will run until 2017 in order to
consolidate the work that has been done and to strengthen the sustainability of
the programme in each country.

1. Beran, Yudkin, Diabetes care in sub-Saharan Africa, 2006
リンク

About Changing Diabetes(R) in Children

The programme is run as a private-public partnership between Novo Nordisk,
Roche, the International Society for Pediatric and Adolescent Diabetes (ISPAD)
and the World Diabetes Foundation (WDF). In each country (Cameroon, Democratic
Republic of Congo, Ethiopia, Guinea, Kenya, Tanzania and Uganda, Bangladesh and
India), the programme is implemented by a group of local partners with the
national Ministry of Health playing a key role to ensure that the programme is
anchored within the existing healthcare system.

Being part of the programme means that each child receives insulin free of
charge along with strips and a glucometer to measure his blood sugar levels.
But since type 1 diabetes is a chronic condition which needs to be monitored
closely, insulin does not do it alone. Therefore, patient education for
children and families and training of healthcare personnel is an essential part.

Further information     
Charlotte Zarp-Andersson     
+45-4442-7603     
czpa@novonordisk.com

(Logo: リンク )

Source: Novo Nordisk




本プレスリリースは発表元企業よりご投稿いただいた情報を掲載しております。
お問い合わせにつきましては発表元企業までお願いいたします。